HOME > 教室について > 業績リスト > 【発表論文】英文 > 2016年

2016年

  1. Kimura T. Future Research Perspective to Improve Outcomes of Bifurcation 2-Stenting. JACC Cardiovasc Interv. 2016 Sep 26;9(18):1887-9.
  2. Ono K. A Novel Link between Plasma MicroRNA-33b Levels and Lipid Disorders in Diabetes Mellitus. J Atheroscler Thromb. 2016 Nov 1;23(11):1259-1260. Epub 2016 Jul 29.
  3. Nakagawa Y, Nishikimii T, Kuwahara K, Fujishima A, Oka Shingo, Tsutamoto T, Kinoshita H, Nakao K, Cho K, Inazumi H, Okamoto H, Nishida M, Kato T, Fukushima H, Yamashita JK, Wijnen W, Creemers EE, Kangawa K, Minamino N, Nakao K, Kimura T. MiR30-GALNT1/2 axis-mediated glycosylation contributes to the increased secretion of inactive human pro-BNP from failing hearts. J Am Heart Assoc. 2016 in press.
  4. Saito N. A reason why visual-functional mismatch happens: Insights from mathematical models. Int J Cardiol. 2016 Mar 1;206:61-3. Epub 2016 Jan 6.
  5. Saito N. Regarding article, “A multi-artery fractional flow reserve (FFR) approach for handling coronary stenosis–stenosis interaction in the multi-vessel disease (MVD) arena.” Int J Cardiol. 2016 Jul 1;214:526-7. Epub 2016 Mar 31.
  6. Kato T, Hirose S, Kumagai S, Ozaki A, Matsumoto S, Inoko M. Electrocardiography as the first step for the further examination of cardiac involvement in myasthenia gravis. Biomed Res Int. 2016;2016:8058946. Epub 2016 Jan 17.
  7. Kato T. A data sheet for the simultaneous assessment of dual radiotracer uptake in the heart. MethodsX. 2016 Apr 2;3:289-96. eCollection 2016.
  8. Imai M, Fukuda A, Miyamoto N, Sako H, Kimura T, FJCC, Inoue K. Pathological analysis of a case with peri-stent contrast staining after BMS implantation. Journal of Cardiology Cases. Volume 14, Issue 6, December 2016, Pages 161–163.
  9. Shiomi H, Yamaji K, Morimoto T, Shizuta S, Nakatsuma K, Higami H, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T. Very Long-Term (10 to 14 Year) Outcomes After Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Multivessel Coronary Artery Disease in the Bare-Metal Stent Era. Circ Cardiovasc Interv. 2016 Aug;9(8). pii: e003365.
  10. Nishi K, Sato Y, Ohno M, Hiraoka Y, Saijo S, Sakamoto J, Chen PM, Morita Y, Matsuda S, Iwasaki K, Sugizaki K, Harada N, Mukumoto Y, Kiyonari H, Furuyama K, Kawaguchi Y, Uemoto S, Kita T, Inagaki N, Kimura T, Nishi E. Nardilysin Is Required for Maintaining Pancreatic β-Cell Function. Diabetes. 2016 Oct;65(10):3015-27. Epub 2016 Jul 6.
  11. Nishiga M, Horie T, Kuwabara Y, Nagao K, Baba O, Nakao T, Nishino T, Hakuno D, Nakashima Y, Nishi H, Nakazeki F, Ide Y, Koyama S, Kimura M, Hanada R, Nakamura T, Inada T, Hasegawa K, Conway SJ, Kita T, Kimura T, Ono K. MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol. Circ Res. 2016 Dec 5. pii: CIRCRESAHA.116.309528. [Epub ahead of print]
  12. Kawaji T, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Mizoguchi T, Abe M, Takahashi M, Kimura T; CREDO-Kyoto AMI investigators. Long-term clinical outcomes in patients with ST-segment elevation acute myocardial infarction complicated by cardiogenic shock due to acute pump failure. Eur Heart J Acute Cardiovasc Care. 2016 Oct 5. pii: 2048872616673535. [Epub ahead of print]
  13. Kawaji T, Shiomi H, Morishita H, Morimoto T, Taylor CA, Kanao S, Koizumi K, Kozawa S, Morihiro K, Watanabe H, Tazaki J, Imai M, Saito N, Shizuta S, Ono K, Togashi K, Kimura T. Feasibility and diagnostic performance of fractional flow reserve measurement derived from coronary computed tomography angiography in real clinical practice. Int J Cardiovasc Imaging. 2016 Oct 7. [Epub ahead of print]
  14. Kawaji T, Shizuta S, Makiyama T, Kimura T. Early-onset Atrial Fibrillation in Brothers with a Huge Left Atrial Appendage. Intern Med. 2016;55(9):1117-20. Epub 2016 May 1.
  15. Tsujimura A, Saito N, Minakata K, Kimura T. Distal coronary embolisation during transcatheter aortic valve implantation. BMJ Case Rep. 2016 Jul 7;2016. pii: bcr2016216620.
  16. Fujita T, Saito N, Minakata K, Imai M, Yamazaki K, Kimura T. Transfemoral transcatheter aortic valve implantation in the presence of a mechanical mitral valve prosthesis using a dedicated TAVI guidewire: utility of a patient-specific three-dimensional heart model. Cardiovasc Interv Ther. 2016 Aug 27. [Epub ahead of print]
  17. Yamamoto E, Saito N, Matsuo H, Kawase Y, Watanabe S, Bao B, Watanabe H, Higami H, Nakatsuma K, Kimura T. Prediction of the true fractional flow reserve of left main coronary artery stenosis with concomitant downstream stenoses: in vitro and in vivo experiments. EuroIntervention. 2016 Feb;11(11):e1249-56.
  18. Yamamoto E, Kato T, Ozasa N, Yaku H, Inuzuka Y, Tamaki Y, Kitai T, Morimoto T, Taniguchi R, Iguchi M, Kato M, Takahashi M, Jinnai T, Ikeda T, Nagao K, Kawai T, Komasa A,Nishikawa R, Kawase Y, Morinaga T,Kawashima T, Motohashi Y, Kawato M, Toyofuku M, Sato Y, Kuwahara K, Shioi T, Kimura T, on behalfof the KCHF study investigators. Kyoto Congestive Heart Failure (KCHF) Study: Rationale and Design. ESC Heart Fail. 2016 in press.
  19. Funakoshi S, Miki K, Takaki T, Okubo C, Hatani T, Chonabayashi K, Nishikawa M, Takei I, Oishi A, Narita M, Hoshijima M, Kimura T, Yamanaka S, Yoshida Y. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep. 2016 Jan 8;6:19111.
  20. Toyota T, Morimoto T, Shiomi H, Ando K, Ono K, Shizuta S, Kato T, Saito N, Furukawa Y, Nakagawa Y, Horie M, Kimura T. Ad-hoc versus non-ad-hoc percutaneous coronary intervention strategies in patients with stable coronary artery disease. Circulation journal. In press.
  21. Taniguchi T, Morimoto T, Sakata R, Kimura T. Reply: Is it Time for a New Paradigm in Asymptomatic Severe Aortic Stenosis?: Asymptomatic Severe Aortic Stenosis: Oxymoron? A Randomized Trial in Patients With Asymptomatic Severe Aortic Stenosis: A Future Has Begun! Might Outcome of Patients With Asymptomatic Severe AS Be Improved by an Initial Surgical Strategy? J Am Coll Cardiol. 2016 Apr 26;67(16):1972-3.
  22. Taniguchi T, Shiomi H, Kosuge M, Morimoto T, Nakatsuma K, Nishiga M, Sasa T, Saito N, Kimura T. Prognostic Significance of ST-Segment Elevation in Leads V1-2 in Patients With Severe Aortic Stenosis. Circ J. 2016;80(2):526-34. Epub 2016 Jan 8.
  23. Nakatsuma K, Saito N, Watanabe H, Bao B, Yamamoto E, Watanabe S, Kimura T, Inoue K. Antegrade transcatheter aortic valve implantation using the looped Inoue balloon technique: A pilot study in a swine model. J Cardiol. 2017 Jan;69(1):260-263. Epub 2016 May 8.
  24. Nakatsuma K, Shiomi H, Morimoto T, Furukawa Y, Nakagawa Y, Ando K, Kadota K, Yamamoto T, Suwa S, Horie M, Kimura T; CREDO-Kyoto AMI investigators. Inter-Facility Transfer vs. Direct Admission of Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Circ J. 2016 Jul 25;80(8):1764-72. Epub 2016 Jun 28.
  25. Nakatsuma K, Yamamoto E, Watanabe S, Bao B, Watanabe H, Kawase Y, Shizuta S, Kimura T, Saito N. Ultrathin Endoscopy-Guided Pericardiocentesis: A Pilot Study in a Swine Model. J Invasive Cardiol. 2016 Mar;28(3):78-80.
  26. Koyama S, Kuragaichi T, Sato Y, Kuwabara Y, Usami S, Horie T, Baba O, Hakuno D, Nakashima Y, Nishino T, Nishiga M, Nakao T, Arai H, Kimura T, Ono K. Dynamic Changes of Serum MicroRNA-122-5p through Therapeutic Courses Indicates Amelioration of Acute Liver Injury Accompanied by Acute Cardiac Decompensation. ESC Heart Failure. 2016 in press.
  27. Inazumi H, Koyama S, Tanada Y, Fujiwara H, Takatsu Y, Sato Y. Prognostic significance of changes in cystatin C during treatment of acute cardiac decompensation. J Cardiol. 2016 Jan;67 (1):98-103. Epub 2015 Jun 15.
  28. Ando K, Ishii K, Tada E, Kataoka K, Hirohata A, Goto K, Kobayashi K, Tsutsui H, Nakahama M, Nakashima H, Uchikawa S, Kanda J, Yasuda S, Yajima J, Kitabayashi H, Sakurai S, Nakanishi K, Inoue N, Noike H, Hasebe T, Sato T, Yamasaki M, Kimura T. Prospective multi-center registry to evaluate efficacy and safety of the newly developed diamond-like carbon-coated cobalt-chromium coronary stent system. Cardiovasc Interv Ther. 2016 Jul 22. [Epub ahead of print]
  29. Cannon CP, Gropper S, Bhatt DL, Ellis SG, Kimura T, Lip GY, Steg PG, Ten Berg JM, Manassie J, Kreuzer J, Blatchford J, Massaro JM, Brueckmann M, Ferreiros Ripoll E, Oldgren J, Hohnloser SH; RE-DUAL PCI Steering Committee and Investigators. Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With Stenting. Clin Cardiol. 2016 Oct;39(10):555-564. Epub 2016 Aug 26.
  30. D'Ascenzo F, Abu-Assi E , Raposeiras - Roubín S , Simao Henriques JP, Saucedo J , González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie SP, Fujii T, Correia LC, Kawashiri MA, García-Acuña JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Giordana F, Scarano S, Gaita F, Kowara M, Filipiak KJ, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S. BleeMACS: rationale and design of the study. J Cardiovasc Med (Hagerstown). 2016 Oct;17 (10):744-9.
  31. Eso Y, Takai A, Matsumoto T, Inuzuka T, Horie T, Ono K, Uemoto S, Lee K, Edelmann W, Chiba T, Marusawa H. MSH2 dysregulation is triggered by proinflammatory cytokine stimulation and is associated with liver cancer development. Cancer Res. 2016 Aug 1;76(15):4383-93. Epub 2016 Jun 3.
  32. Fujita T, Saito N, Minakata K, Imai M, Yamazaki K, Kimura T. Transfemoral transcatheter aortic valve implantation in the presence of a mechanical mitral valve prosthesis using a dedicated TAVI guidewire: utility of a patient-specific three-dimensional heart model. Cardiovasc Interv Ther. 2016 Aug 27. [Epub ahead of print]
  33. Fujii Y, Matsumoto Y, Hayashi K, Ding WG, Tomita Y, Fukumoto D, Wada Y, Ichikawa M, Sonoda K, Ozawa J, Makiyama T, Ohno S, Yamagishi M, Matsuura H, Horie M, Itoh H. Contribution of a KCNH2 variant in genotyped long QT syndrome: Romano-Ward syndrome under double mutations and acquired long QT syndrome under heterozygote. J Cardiol. 2016 Nov 2. pii: S0914-5087(16)30219-2. [Epub ahead of print]
  34. Gili S, D'Ascenzo F, Lococo MF, Moretti C, Gaita F, Raposeiras-Roubín S, Abu-Assi E, Henriques JP, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, García-Acuña JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Scarano S, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahashi T, Sakata K, Yamagishi M, Kalpak O, Kedev S. Impact of blood transfusion on in-hospital myocardial infarctions according to patterns of acute coronary syndrome: Insights from the BleeMACS registry. Int J Cardiol. 2016 Oct 15;221:364-70. Epub 2016 Jul 6.
  35. Giordana F, Montefusco A, D'Ascenzo F, Moretti C, Scarano S, Abu-Assi E, Raposeiras-Roubín S, Henriques JP, Saucedo J, González-Juanatey JR, Wilton SB, Kikkert WJ, Nuñez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Huczek Z, Nie SP, Fujii T, Correia L, Kawashiri MA, García-Acuña JM, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, Möllmann H, Shiomi H, Kowara M, Filipiak K, Wang X, Yan Y, Fan JY, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Gaita F. Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe. Int J Cardiol. 2016 Oct 1;220:488-95. Epub 2016 Jun 20.
  36. Giustino G, Mastoris I, Baber U, Sartori S, Stone GW, Leon MB, Serruys PW, Kastrati A, Windecker S, Valgimigli M, Dangas GD, Von Birgelen C, Smits PC, Kandzari D, Galatius S, Wijns W, Steg PG, Stefanini GG, Aquino M, Morice MC, Camenzind E, Weisz G, Jeger RV, Kimura T, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Chieffo A, Mehran R. Correlates and Impact of Coronary Artery Calcifications in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. JACC Cardiovasc Interv. 2016 Sep 26;9 (18):1890-901.
  37. Harrison RW, Radhakrishnan V, Lam PS, Allocco DJ, Brar S, Fahy M, Fisher R, Ikeno F, Généreux P, Kimura T, Liu M, Lye WK, Mintz GS, Nagai H, Suzuki Y, White R, Allen JC Jr, Krucoff MW. Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohorts. Am Heart J. 2016 Dec;182:103-110. Epub 2016 Aug 3.
  38. Hasegawa K, Watanabe H, Hisamatsu T, Ohno S, Itoh H, Ashihara T, Hayashi H, Makiyama T, Minamino T, Horie M. Early repolarization and risk of arrhythmia events in long QT syndrome. Int J Cardiol. 2016 Nov 15;223:540-542. Epub 2016 Aug 11.
  39. Hiwasa T, Zhang XM, Kimura R, Ohno M, Chen PM, Nishi E, Ono K, Kimura T, Kamitsukasa I, Wada T, Aotsuka A, Mine S, Takizawa H, Kashiwado K, Takemoto M, Kobayashi K, Kawamura H, Ishibashi R, Yokote K, Nakamura R, Tomiyoshi G, Shinmen N, Kuroda H. Elevated Adiponectin Antibody Levels in Sera of Patients with Atherosclerosisrelated Coronary Artery Disease, Cerebral Infarction and Diabetes Mellitus. J Circ Biomark. 5:8, 2016.
  40. Ichikawa M, Aiba T, Ohno S, Shigemizu D, Ozawa J, Sonoda K, Fukuyama M, Itoh H, Miyamoto Y, Tsunoda T, Makiyama T, Tanaka T, Shimizu W, Horie M. Phenotypic Variability of ANK2 Mutations in Patients With Inherited Primary Arrhythmia Syndromes. Circ J. 2016 Nov 25;80 (12):2435-2442. Epub 2016 Oct 25.
  41. Kai H, Kimura T, Fukuda K, Fukumoto Y, Kakuma T, Furukawa Y; CREDO-Kyoto Investigators. Impact of Low Diastolic Blood Pressure on Risk of Cardiovascular Death in Elderly Patients With Coronary Artery Disease After Revascularization - The CREDO-Kyoto Registry Cohort-1. Circ J. 2016 Apr 25;80(5):1232-41.
  42. Kawamura T, Miyagawa S, Fukushima S, Maeda A, Kashiyama N, Kawamura A, Miki K, Okita K, Yoshida Y, Shiina T, Ogasawara K, Miyagawa S, Toda K, Okuyama H, Sawa Y. Cardiomyocytes Derived from MHC-Homozygous Induced Pluripotent Stem Cells Exhibit Reduced Allogeneic Immunogenicity in MHC-Matched Non-human Primates. Stem Cell Reports. 2016 Mar 8;6(3):312-20.
  43. Kereiakes DJ, Ellis SG, Kimura T, Abizaid A, Zhao W, Veldhof S, Vu MT, Zhang Z, Onuma Y, Chevalier B, Serruys PW, Stone GW. Efficacy and Safety of the Absorb Everolimus-Eluting Bioresorbable Scaffold for Treatment of Patients With Diabetes Mellitus: Results of the Absorb Diabetic Substudy. JACC Cardiovasc Interv. 2016 Dec 1. pii: S1936-8798 (16)31841-6. [Epub ahead of print]
  44. Kitai T, Taniguchi T, Morimoto T, Toyota T, Izumi C, Kaji S, Kim K, Saito N, Nagao K, Inada T, Minamino-Muta E, Kato T, Inoko M, Ishii K, Koyama T, Sakata R, Furukawa Y, Kimura T; CURRENT AS registry Investigators. Different clinical outcomes in patients with asymptomatic severe aortic stenosis according to the stage classification: Does the aortic valve area matter? Int J Cardiol. 2016 Nov 11;228:244-252. [Epub ahead of print]
  45. Kitajima N, Numaga-Tomita T, Watanabe M, Kuroda T, Nishimura A, Miyano K, Yasuda S, Kuwahara K, Sato Y, Ide T, Birnbaumer L, Sumimoto H, Mori Y, Nishida M. TRPC3 positively regulates reactive oxygen species driving maladaptive cardiac remodeling. Sci Rep. 2016 Nov 11;6:37001.
  46. Mori KP, Yokoi H, Kasahara M, Imamaki H, Ishii A, Kuwabara T, Koga K, Kato Y, Toda N, Ohno S, Kuwahara K, Endo T, Nakao K, Yanagita M, Mukoyama M, Mori K. Increase of Total Nephron Albumin Filtration and Reabsorption in Diabetic Nephropathy. J Am Soc Nephrol. 2017 Jan;28(1):278-289. Epub 2016 Jul 6.
  47. Morita Y, Andersen P, Hotta A, Tsukahara Y, Sasagawa N, Hayashida N, Koga C, Nishikawa M, Saga Y, Evans SM, Koshiba-Takeuchi K, Nishinakamura R, Yoshida Y, Kwon C, Takeuchi JK. Sall1 transiently marks undifferentiated heart precursors and regulates their fate. J Mol Cell Cardiol. 2016 Mar;92:158-62.
  48. Morita Y, Kato T, Okano M, Su K, Kimura M, Minamino-Muta E, Nakane E, Izumi T, Miyamoto S, Haruna T, Ueyama K, Inoko M. Incidence and predictors of catheterization -related cerebral infarction on diffusion-weighted magnetic resonance imaging. Biomed Res Int. 2016;2016:6052125. Epub 2016 Apr 5.
  49. Murase K, Ono K, Yoneda T, Iguchi M, Yokomatsu T, Mizoguchi T, Izumi T, Akao M, Miki S, Nohara R, Ueshima K, Mishima M, Kimura T, White DP, Chin K. Adaptive servoventilation versus oxygen therapy for sleep disordered breathing in patients with heart failure: a randomized trial. Open Heart. 2016 Mar 31;3(1):e000366.
  50. Nakagawa H, Mizuno Y, Harada E, Morikawa Y, Kuwahara K, Saito Y, Yasue H. Brain Natriuretic Peptide Counteracting the Renin-angiotensin-aldosterone System in Accelerated Malignant Hypertension. Am J Med Sci. 2016 Nov;352(5):534-539. Epub 2016 Aug 3.
  51. Nakao K, Kuwahara K, Nishikimi T, Nakagawa Y, Kinoshita H, Minami T, Kuwabara Y, Yamada C, Yamada Y, Tokudome T, Nagai-Okatani C, Minamino N, Nakao YM, Yasuno S, Ueshima K, Sone M, Kimura T, Kangawa K, Nakao K. Endothelium-derived C-type natriuretic peptide contributes to blood pressure regulation by maintaining endothelial integrity. Hypertension. 2017 Feb;69(2):286-296. Epub 2017 Jan 3.
  52. Nakayoshi T, Ueno T, Sasaki KI, Yokoyama S, Ohtsuka M, Mitsutake Y, Itaya N, Chibana H, Sasaki M, Ishimatsu T, Kimura T, Fukumoto Y. Differential angioscopic findings of neointimal coverage among first-, second-, and next generation drug-eluting stents. Int J Cardiol. 2016 Nov 15;223:450-451.
  53. Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shiomi H, Toyota T, Watanabe H, Ono K, Shizuta S, Tamura T, Inoko M, Inada T, Shirotani M, Matsuda M, Aoyama T, Onodera T, Suwa S, Takeda T, Inoue K, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators. Short versus prolonged dual antiplatelet therapy duration after bare-metal stent implantation: 2-month landmark analysis from the CREDO-Kyoto registry cohort-2. Cardiovasc Interv Ther. 2016 Sep 19. [Epub ahead of print]
  54. Nishi T, Takaoka H, Funabashi N, Nishimura M, Ohara O, Makiyama T, Ueda M, Kajiyama T, Kobayashi Y. Familial lamin A/C mutation cardiomyopathy with arrhythmia substrate detected by cardiac magnetic resonance imaging and electroanatomical mapping. Int J Cardiol. 2016 Apr 15;209:248-52. Epub 2016 Feb 4.
  55. Nishizawa M, Chonabayashi K, Nomura M, Tanaka A, Nakamura M, Inagaki A, Nishikawa M, Takei I, Oishi A, Tanabe K, Ohnuki M, Yokota H, Koyanagi-Aoi M, Okita K, Watanabe A, Takaori-Kondo A, Yamanaka S, Yoshida Y. Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity. Cell Stem Cell. 2016 Sep 1;19(3):341-54.
  56. Numaga-Tomita T, Kitajima N, Kuroda T, Nishimura A, Miyano K, Yasuda S, Kuwahara K, Sato Y, Ide T, Birnbaumer L, Sumimoto H, Mori Y, Nishida M. TRPC3-GEF-H1 axis mediates pressure overload-induced cardiac fibrosis. Sci Rep. 2016 Dec 19;6:39383.
  57. Oceguera-Yanez F, Kim SI, Matsumoto T, Tan GW, Xiang L, Hatani T, Kondo T, Ikeya M, Yoshida Y, Inoue H, Woltjen K. Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives. Methods. 2016 May 15;101:43-55.
  58. Ohno S, Yokoi H, Mori K, Kasahara M, Kuwahara K, Fujikura J, Naito M, Kuwabara T, Imamaki H, Ishii A, Saleem MA, Numata T, Mori Y, Nakao K, Yanagita M, Mukoyama M. Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure. Sci Rep. 2016 Jun 7;6:27192.
  59. Ohta Y, Miki I, Kimura T, Abe M, Sakuma M, Koike K, Morimoto T. Epidemiology of Adverse Events and Medical Errors in the Care of Cardiology Patients. J Patient Saf. 2016 Nov 2. [Epub ahead of print]
  60. Ohya M, Kadota K, Sotomi Y, Kozuma K, Tanabe K, Uematsu M, Kawasaki T, Morino Y, Tobaru T, Nakao K, Tachibana K, Kishi K, Shibata Y, Ying S, Kusano H, Stone GW, Popma JJ, Onuma Y, Serruys PW, Kimura T. Impact of lesion calcification on angiographic outcomes after Absorb everolimus-eluting bioresorbable vascular scaffold implantation: an observation from the ABSORB Japan trial. EuroIntervention. 2016 Nov 8. pii: EIJ-D-16-00359. [Epub ahead of print]
  61. Ohya M, Kadota K, Toyofuku M, Morimoto T, Higami H, Fuku Y, Yamaji K, Muranishi H, Yamaji Y, Nishida K, Furukawa D, Tada T, Ko E, Ando K, Sakamoto H, Tamura T, Kawai K, Kimura T; AOI LMCA Stenting Registry Investigators. Long-Term Outcomes After Stent Implantation for Left Main Coronary Artery (from the Multicenter Assessing Optimal Percutaneous Coronary Intervention for Left Main Coronary Artery Stenting Registry). Am J Cardiol. 2016 Oct 31. pii: S0002-9149(16)31744-1. [Epub ahead of print]
  62. Onuma Y, Sotomi Y, Shiomi H, Ozaki Y, Namiki A, Yasuda S, Ueno T, Ando K, Furuya J, Igarashi K, Kozuma K, Tanabe K, Kusano H, Rapoza R, Popma JJ, Stone GW, Simonton C, Serruys PW, Kimura T. Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial. EuroIntervention. 2016 Oct 20;12(9):1090-1101.
  63. Ozawa J, Ohno S, Hisamatsu T, Itoh H, Makiyama T, Suzuki H, Saitoh A, Horie M. Pediatric Cohort With Long QT Syndrome - KCNH2 Mutation Carriers Present Late Onset But Severe Symptoms. Circ J. 2016;80(3):696-702. Epub 2016 Jan 26.
  64. Parr CJ, Katayama S, Miki K, Kuang Y, Yoshida Y, Morizane A, Takahashi J, Yamanaka S, Saito H. MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells. Sci Rep. 2016 Sep 9;6:32532.
  65. Sasaki K, Makiyama T, Yoshida Y, Wuriyanghai Y, Kamakura T, Nishiuchi S, Hayano M, Harita T, Yamamoto Y, Kohjitani H, Hirose S, Chen J, Kawamura M, Ohno S, Itoh H, Takeuchi A, Matsuoka S, Miura M, Sumitomo N, Horie M, Yamanaka S, Kimura T. Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia. PLoS One. 2016 Oct 20;11(10):e0164795.
  66. Setozaki S, Minakata K, Masumoto H, Hirao S, Yamazaki K, Kuwahara K, Ikeda T, Sakata R. Prevention of abdominal aortic aneurysm progression by oral administration of green tea polyphenol in a rat model. J Vasc Surg. 2016 Jul 26. pii: S0741-5214(16)30419-0. [Epub aheadof print]
  67. Shiba M, Kato T, Funasako M, Nakane E, Miyamoto S, Izumi T, Haruna T, Inoko M. Association between psoriasis vulgaris and coronary heart disease in a hospital-based population in Japan. PLoS One. 2016 Feb 24;11(2):e0149316. eCollection 2016.
  68. Shiraishi Y, Kujiraoka T, Hakuno D, Masaki N, Tokuno S, Adachi T. Elevation of derivatives of reactive oxygen metabolites elevated in young "disaster responders" in hypertension due to great east japan earthquake. Int Heart J. 2016;57(1):61-6. Epub 2016 Jan 8.
  69. Sonoda K, Ohno S, Otuki S, Kato K, Yagihara N, Watanabe H, Makiyama T, Minamino T, Horie M. Quantitative analysis of PKP2 and neighbouring genes in a patient with arrhythmogenic right ventricular cardiomyopathy caused by heterozygous PKP2 deletion. Europace. 2016 Mar 22. pii: euw038. [Epub ahead of print]
  70. Sotomi Y, Onuma Y, Suwannasom P, Tateishi H, Tenekecioglu E, Zeng Y, Cavalcante R, Jonker H, Dijkstra J, Foin N, Koon JN, Collet C, de Winter RJ, Wykrzykowska JJ, Stone GW, Popma JJ, Kozuma K, Tanabe K, Serruys PW, Kimura T. Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold? EuroIntervention. 2016 Oct 10;12(8):e998-e1008.
  71. Stone GW, Gao R, Kimura T, Simonton C, Serruys PW. Optimum technique to reduce risk of stent thrombosis - Authors' reply. Lancet. 2016 Jul 9;388(10040):127-8.
  72. Takimoto S, Saito N, Minakata K, Shirai S, Isotani A, Arai Y, Hanyu M, Komiya T, Shimamoto T, Goto T, Fuku Y, Ehara N, Furukawa Y, Koyama T, Nagasawa A, Tamura T, Miyake M, Yamanaka K, Sakaguchi H, Murata K, Onodera T, Yamazaki F, Nakai M, Taniguchi T, Sakata R, Kimura T. Favorable Clinical Outcomes of Transcatheter Aortic Valve Implantation in Japanese Patients - First Report From the Post-Approval K-TAVI Registry. Circ J. 2016 Dec 22;81(1):103-109. Epub 2016 Dec 3.
  73. Turker I, Makiyama T, Vatta M, Itoh H, Ueyama T, Shimizu A, Ai T, Horie M. A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG. PLoS One. 2016 Aug 25;11 (8):e0161872. eCollection 2016.
  74. Vlachojanni GJ, Puricel S, Natsuaki M, Morimoto T, Smits PC, Kimura T. Biolimus-eluting versus Everolimus-eluting Stents in Coronary Artery Disease A Pooled Analysis from the NEXT and COMPARE II Randomized Trials. EuroIntervention. 2016 Nov 2. pii: EIJ-D-16-00773. [Epub ahead of print]
  75. Yamaji K, Shiomi H, Morimoto T, Nakatsuma K, Toyota T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shirai S, Onodera T, Watanabe H, Natsuaki M, Sakata R, Hanyu M, Nishiwaki N, Komiya T, Kimura T. Effects of Age and Sex on Clinical Outcomes after Percutaneous Coronary Intervention Relative to Coronary Artery Bypass Grafting in Patients with Triple Vessel Coronary Artery Disease. Circulation. 2016 May 10;133(19):1878-91. Epub 2016 Mar 23.
  76. Yamashita Y, Yamada-Goto N, Katsuura G, Ochi Y, Kanai Y, Miyazaki Y, Kuwahara K, Kanamoto N, Miura M, Yasoda A, Ohinata K, Inagaki N, Nakao K. Brain-specific natriuretic peptide receptor-B deletion attenuates high-fat diet-induced visceral and hepatic lipid deposition in mice. Peptides. 2016 Jul;81:38-50. Epub 2016 Mar 25.
  77. Yasuda M, Iwanaga Y, Kato T, Izumi T, Inuzuka Y, Nakamura T, Miyaji Y, Kawamura T, Ikeguchi S, Inoko M, Kurita T, Miyazaki S. Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis. Open Heart. 2016 Aug 1;3(2):e000437. eCollection 2016.
  78. Yoon WH, Sandoval H, Nagarkar-Jaiswal S, Jaiswal M, Yamamoto S, Haelterman NA, Putluri N, Putluri V, Sreekumar A, Tos T, Aksoy A, Donti T, Graham BH, Ohno M, Nishi E, Hunter J, Muzny DM, Carmichael J, Shen J, Arboleda VA, Nelson SF, Michael F. Wangler MF, Karaca E, Lupski JR, and Bellen HJ. Loss of Nardilysin, a Mitochondrial Co-chaperone for α-Ketoglutarate Dehydrogenase, Promotes mTORC1 Activation and Neurodegeneration. Neuron. 2017 Jan 4;93(1):115-131. Epub 2016 Dec 22.
  79. Yoshida Y, Yamanaka S. Understanding Intracellular Signaling Advances Cardiac Reprogramming Technology Toward Clinical Applications. Circ Res. 2016 Feb 5;118(3):377-8.
  80. Zhou Z, Yano I, Odaka S, Morita Y, Shizuta S, Hayano M, Kimura T, Akaike A, Inui K, Matsubara K. Effect of vitamin K2 on the anticoagulant activity of warfarin during the perioperative period of catheter ablation: Population analysis of retrospective clinical data. J Pharm Health Care Sci. 2016 Aug 4;2:17.
  81. Nishikimi T, Kuwahara K, Nakagawa Y, Kangawa K, and Nakao K. Endocrinology of the Heart in Health and Disease. Chapter 2 Adrenomedullin. Edit by Jonathan C. Schisler, Charles H. Lang, Monte S. Willis. Publisher;Elsevier Scinence. Imprint:Academic Press. pp.41-58 2016. ISBN:9780128031117(単行本)
<< 2015年｜ 業績リストTOP ｜2017年 >>
ページの先頭へ